Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • YAP
    (8)
  • Others
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (7)
  • Immune System
    (1)
Filter
Search Result
Results for "

yap/taz inhibitor-1

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    8
    TargetMol | All_Pathways
  • YAP/TAZ inhibitor-1
    T133642093565-23-0
    YAP/TAZ inhibitor-1 is a YAP/TAZ inhibitor (IC50 <0.100 μΜ) for the study of abnormal immune function and cancer.
    • $487
    5 days
    Size
    QTY
    TargetMol | Citations Cited
  • GA-017
    T600132351906-74-4
    GA-017 is a potent, selective inhibitor of LATS1 and LATS2 (large tumor suppressor kinase 1/2), exhibiting IC50 values of 4.10 and 3.92 nM, respectively. This compound simultaneously acts as an activator of cell proliferation by promoting YAP/TAZ activation and their nuclear translocation. Additionally, GA-017 enhances cell growth in 3D culture conditions and augments the ex vivo formation of mouse intestinal organoids [1].
    • $97
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Hot
  • pan-TEAD-IN-1
    T2035003027484-09-6
    pan-TEAD-IN-1 (Compound 3) is an orally active pan-inhibitor of TEAD, disrupting its interaction with coactivators YAP/TAZ by targeting the palmitoylation site of TEAD. This inhibition leads to the downregulation of oncogene transcription, such as Ctgf and Cyr61, within the Hippo signaling pathway. Demonstrating outstanding efficacy, pan-TEAD-IN-1 has an IC50 of 0.36 nM for luciferase and 1.52 nM for H226 cells, along with favorable pharmacokinetic properties (AUC0–∞= 228.7 μg/mL·min, T1/2= 183.9 min). The compound significantly inhibits tumor growth in xenograft models of TEAD-dependent cancers, indicating its potential for research in these cancer types.
    • $1,520
    4-6 weeks
    Size
    QTY
  • TEAD1/3/4-IN-1
    T2078122762619-63-4
    TEAD1/3/4-IN-1 (compound 1) is an inhibitor of TEAD1/3/4 that suppresses YAP/TAZ-TEAD interactions. It exhibits antitumour activity against NF2-deficient NCI-H226 cells and may be employed in studies of cancer and diseases mediated by Hippo pathway abnormalities.
    • $50
    In Stock
    Size
    QTY
  • MSC-4106
    T601482738542-58-8
    MSC-4106, an orally active and potent YAP/TAZ-TEAD inhibitor, disrupts TEAD1 and TEAD3 auto-palmitoylation and demonstrates significant efficacy in the NCI-H226 tumor xenograft model [1].
    • $97
    In Stock
    Size
    QTY
  • YAP/TAZ inhibitor-2
    T602182762617-31-0
    YAP/TAZ inhibitor-2 is a potent, orally active TEAD-YAP/TAZ inhibitor with an EC50 value of 3 nM, demonstrating anti-proliferative and antitumor activity [1].
    • $84
    In Stock
    Size
    QTY
  • SWTX-143
    T810562766575-48-6
    SWTX-143, a novel covalent inhibitor, specifically and irreversibly binds to the palmitoylation pocket of all four TEAD isoforms, inhibiting the transcriptional activity of the YAP/TAZ-TEAD complex and demonstrating antitumor activity [1].
    • $258
    8-10 weeks
    Size
    QTY
  • YAP/TAZ inhibitor-3
    T876512506273-81-8
    YAP/TAZ inhibitor-3 (Compound 24) is a YAP/TAZ inhibitor applicable for relevant research within the life sciences field.
    • $97
    In Stock
    Size
    QTY